Navigation Links
Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
Date:7/30/2008

LONDON, July 30 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN), a leading European RNAi focused biotechnology company, today announces that its partner, Quark Pharmaceuticals Inc. ("Quark") together with Pfizer, has commenced a Phase II clinical trial with RTP-801i-14 (PF-4523655), a small interfering RNA (siRNA) therapeutic product based on Silence's AtuRNAi technology. Its initiation triggers a $1.9 million milestone payment to Silence from Quark.

The study is designed to evaluate the effectiveness of the candidate in improving visual acuity compared to laser treatment in patients with diabetic macular oedema. The Phase II study is being funded and is conducted by Pfizer Inc. in collaboration with Quark. Pfizer in-licensed RTP-801i-14 from Quark in a deal announced in 2006 for the treatment of age-related macular degeneration (AMD) and other ophthalmologic and non-ophthalmologic indications.

Diabetic macular oedema results in the macula swelling and surrounding blood vessels dilating to compensate for this. The dilated vessels are generally leaky, resulting in fluid build-up in the macula, which in turn causes the macula to swell and cease to function. Diabetic macular oedema is the most common cause of visual impairment in patients with non-proliferative retinopathy. Approximately 14% of people with diabetes have diabetic macular oedema with prevalence increasing to 29% for people with diabetes who use insulin for more than 20 years.

In December 2004 Quark and Silence Therapeutics AG signed a Collaboration Agreement on the development of siRNA molecules for the gene target RTP-801, which resulted in RTP801i-14, a 19 base pairs long blunt-ended AtuRNAi (siRNA) molecule and also provided Quark with a license to AtuRNAi technology. In addition a second agreement (Option and License Agreement) was signed in April 2005, and expanded in 2007, to provide Quark with options for non-exclusive licenses to develop additional molecules agains
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
2. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
3. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
4. Silence Therapeutics Announces Board Changes
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
8. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , Mar. 30, 2015 Research and Markets ... addition of the "Eurpoean Automatic External Defibrillators ... (Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, ... their offering. The European automated external ... a CAGR of 10.9% from 2014 to 2019 ...
(Date:3/31/2015)... March 31, 2015 According ... and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, ... Incubator, Fume Hood, Centrifuge) - Global Forecast to ... and Chemical Instrumentation Market is expected to reach ... from 2014 to 2019. Browse ...
(Date:3/31/2015)... 2015  Mark Farrah Associates (MFA), www.markfarrah.com ... plans in their recent analysis brief.  According to ... in Medicare Advantage plans as of March 2015, ... year-over-year.  54.3 million people are eligible for Medicare, ... Services (CMS), with an unpenetrated market of 37 ...
Breaking Medicine Technology:Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2
... 100% with ... Masimo,s PI measurement, IRVINE, Calif., Nov. 14 ... and Low,Perfusion pulse oximetry, reported that a new independent and objective,clinical ... detection of congenital heart defects (CHD) in newborns with,duct-dependent systemic circulation. ...
... Current Research Findings on the ... Treatment of Localized Prostate Cancer, TORONTO, Nov. 14 ... the Sonablate(R) 500 - a Health Canada,approved treatment for localized ... AstraZeneca Canada Inc, Can-Am HIFU, a prostate,cancer treatment centre, will ...
Cached Medicine Technology:New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 2New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 3New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 4Prostate Cancer Treatment Centre Receives Funding for Clinical Trials 2
(Date:3/31/2015)... 31, 2015 BESLER Consulting today ... “The Value of an Independent Cost Report Review.” ... a critical role in the determination of Medicare ... appropriate understanding and review, this report can assist ... planning. , This white paper discusses:, ...
(Date:3/31/2015)... 31, 2015 With intravenous (IV) infusion ... a catheter. Patients, typically, are prescribed IV infusion therapy ... medications are no longer effective. Illness often leads ... help with electrolyte imbalances. Infusion therapy benefits the ... addition to treating dehydration, IV infusion therapy can be ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Williams ... a repair visit when their home comfort is ... and make the visit fit into the customer’s ... provide fast, quality repair at requested times. ... and commercial customers in the Indianapolis area can ...
(Date:3/31/2015)... 31, 2015 DataEntryOutsourced is ... of data entry experts to handle the specialized requirements ... managing a complex nutritional scoring system for a wide ... trial of their nutrition scale data entry services. ... Case Study on U.S. Food Nutrition Scale Data Entry." ...
(Date:3/31/2015)... The status of more than 1,000 Mirena ... Management Conference scheduled to be held in the U.S. ... 21st. According to court documents, the jurisdiction is currently ... lawsuits filed on behalf of women who allegedly suffered ... to the birth control device. (In re: Mirena IUD ...
Breaking Medicine News(10 mins):Health News:Intravenous Infusion Therapy Now Available at Urgent Care of Texas Centers; Hospital-Level Care in an Outpatient Setting. 2Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2Health News:DEO Announces a Team of Dedicated Data Entry Operators for Nutrition Score Data Entry 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 3
... , , , NORCROSS, Ga., July 23 ... automated instrument-reagent systems to the blood transfusion industry, today reported financial results for ... , Fourth Quarter Financial Highlights , , ... $79.0 million, up 15% from $68.6 million in the same period last year. ...
... SACRAMENTO, Calif., July 23 Oscar Wright, chief executive officer of ... the Psycho Donuts shop, participated in an interview and debate Wednesday on ... , Oscar Wright released this statement today: ... administrator of the U.S. Small Business Administration, I appreciate an individual,s goal ...
... , , , , ... "Reform" Jeopardize Viability of Already-Troubled Texas Medicaid Program; ... , AUSTIN, Texas, July 23 /PRNewswire-USNewswire/ ... to Medicare-financed nursing home care as part of ongoing health reform negotiations ...
... , TROY, Mich., July 23 ... system, many of the country,s citizens are struggling to afford the ... of Americans have taken dangerous measures that can harm their health ... half, failing to fill a prescription or sharing a prescription. ...
... , , Tour Includes Demonstration ... CLEVELAND, July 23 Today, ... its model of healthcare, how it utilizes health information technology, and a ... of how the Clinic provides patients with cost-effective, high-quality clinical results. , ...
... , , , ... NEW YORK, July 23 National Minority Donor Awareness Day is August 1, ... Hudson Valley, Brooklyn/Staten Island, and New Jersey call on the community to help ... , Historically, National Minority Donor Awareness Day emphasized ...
Cached Medicine News:Health News:Immucor Announces Fiscal Fourth Quarter Results 2Health News:Immucor Announces Fiscal Fourth Quarter Results 3Health News:Immucor Announces Fiscal Fourth Quarter Results 4Health News:Immucor Announces Fiscal Fourth Quarter Results 5Health News:Immucor Announces Fiscal Fourth Quarter Results 6Health News:Immucor Announces Fiscal Fourth Quarter Results 7Health News:Immucor Announces Fiscal Fourth Quarter Results 8Health News:Immucor Announces Fiscal Fourth Quarter Results 9Health News:Immucor Announces Fiscal Fourth Quarter Results 10Health News:Mental Health Advocates Call for Psycho Donuts to Do the Right Thing 2Health News:Expressing Growing Concern, THCA Urges Texas Congressional Delegation to Protect Seniors' Medicare-Funded Nursing Home Care as Health Reform Debate Proceeds 2Health News:As the Government Continues to Work Toward Health Care Reform, Medtipster is Providing a Free Solution to Rising Health Care Costs for Americans Right Now 2Health News:President Obama's Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model 2Health News:President Obama's Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model 3Health News:The Gift of Life Flows Through Your Veins! 2Health News:The Gift of Life Flows Through Your Veins! 3
... is the ultimate research stereo microscope ... distance, wide zoom range, excellent image ... by a modular system of mechanical ... great flexibility, allowing adaptation to meet ...
... Nikon Instruments Inc., a world leader ... the introduction of its new Universal ... Nikon Eclipse upright microscope models, including ... This Universal Epi Illuminator provides ...
... color camera, delivers high-resolution images with outstanding detail ... The Q-Color3 is easy to set up and ... CCD - 1/1.8" Color ... bit digitization and preview options ...
... megapixel monochrome microscopy camera suitable for bright-field ... microscopy camera designed to capture publication quality ... resolution and can provide 5 frames per ... For preview, the resolution can be decimated ...
Medicine Products: